Specification

MSDS

TSE / BSE Statement

Retest Statement

• inhibitor, anhydride, propane, hydrochloride, prodrugs, fgfr1 inhibitor, butanoic acid, growth inhibitor, sulfur trioxide, drug composition, insulin-producing, oxidation, trioxide, fluorinated, sulfur, carbamate, carbamate prodrugs, medicines, acyloxyalkyl, acyloxyalkyl carbamate, hydrogen, acyloxyalkyl carbamate prodrugs, solvent, epichlorohydrin, betrixaban, plastics, catalyst, reactions, synthesis, Show more, alkaloid tetracyclic, inhibitor and/or, vegfr inhibitor, vegf inhibitor, oxide, pancreatic β, pharmaceutical, hydrogen bonds, vegfr inhibitor and/or, molecules, fatty acid, hydrogen-bonded, catalysts, glycerol, benzimidazoles, alkenes, carbenes, aromatic, ether, aromatic ether, substituted, hydrogen bonding, pyridine ring, pyridine, monohydrate, dichlorobenzene, pi-pi stacking, crystal structure, hydrogen-bonded chains, structure, crystal, industrial, reagents, oxychloride, phosphorus, phosphorus oxychloride, oxalyl, chloride, synthesised, organofluorine compound, organofluorine, pyrrolidinone, indene, natural product, intermediates, hydroxycinnamic acid, hydroxycinnamic, flavonoids, chondroitin sulfate, chondroitin, pyrazoles, sulfate, inter-molecular, oligopeptide, propanol, mass spectrum, anhydrous, nitrated, density, nitration, benzene, methoxylation, deamination, hydroxy, polyunsaturated, hydroxy fatty, hydroxy fatty acid, crystalline, medium-chain fatty acid, medium-chain fatty, medium-chain, dianion, thiolactomycin, aldehyde, hydroxylation, derivatives, side-chain, solvents, aromatic ring, acetonitrile, therapeutically, organonitrogen heterocyclic compound, heterocyclic, organonitrogen heterocyclic, heterocyclic compound, carbazole, phenyl, phenyl ring, hydrogen peroxide, peroxide, solution, Show less